Standard BioTools (LAB) Competitors $1.27 -0.02 (-1.55%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$1.28 +0.01 (+1.10%) As of 10/17/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAB vs. TXG, EYPT, ALNT, AEHR, TRNS, CTKB, FEIM, SENS, QSI, and MASSShould you be buying Standard BioTools stock or one of its competitors? The main competitors of Standard BioTools include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Transcat (TRNS), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), Senseonics (SENS), Quantum-Si (QSI), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Standard BioTools vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Allient Aehr Test Systems Transcat Cytek Biosciences Frequency Electronics Senseonics Quantum-Si 908 Devices 10x Genomics (NASDAQ:TXG) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Is TXG or LAB more profitable? 10x Genomics has a net margin of -13.13% compared to Standard BioTools' net margin of -69.08%. 10x Genomics' return on equity of -12.88% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Standard BioTools -69.08%-20.23%-15.32% Which has stronger earnings and valuation, TXG or LAB? Standard BioTools has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.41-$182.63M-$0.70-16.90Standard BioTools$174.43M2.78-$138.88M-$0.32-3.97 Does the media prefer TXG or LAB? In the previous week, 10x Genomics had 16 more articles in the media than Standard BioTools. MarketBeat recorded 17 mentions for 10x Genomics and 1 mentions for Standard BioTools. 10x Genomics' average media sentiment score of 0.61 beat Standard BioTools' score of 0.00 indicating that 10x Genomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Standard BioTools 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, TXG or LAB? 10x Genomics has a beta of 2.05, meaning that its stock price is 105% more volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Do analysts rate TXG or LAB? 10x Genomics currently has a consensus target price of $13.65, suggesting a potential upside of 15.42%. Standard BioTools has a consensus target price of $1.55, suggesting a potential upside of 22.05%. Given Standard BioTools' higher possible upside, analysts plainly believe Standard BioTools is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 2 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.38Standard BioTools 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Do institutionals & insiders believe in TXG or LAB? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 23.2% of Standard BioTools shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Summary10x Genomics beats Standard BioTools on 11 of the 17 factors compared between the two stocks. Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAB vs. The Competition Export to ExcelMetricStandard BioToolsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$485.13M$2.25B$6.14B$10.56BDividend YieldN/AN/A5.72%4.83%P/E Ratio-3.9739.7185.7027.05Price / Sales2.7812.90612.92132.35Price / CashN/A59.9325.8230.35Price / Book1.0012.2912.226.58Net Income-$138.88M-$65.79M$3.33B$276.84M7 Day Performance-0.78%0.97%1.17%1.93%1 Month Performance-9.29%4.06%6.85%2.19%1 Year Performance-33.16%30.24%58.93%34.62% Standard BioTools Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABStandard BioTools2.3467 of 5 stars$1.27-1.6%$1.55+22.0%-33.2%$485.13M$174.43M-3.97620News CoverageGap UpTXG10x Genomics4.3979 of 5 stars$11.60+1.1%$13.65+17.7%-23.4%$1.43B$610.78M-16.571,240Trending NewsAnalyst ForecastAnalyst RevisionEYPTEyepoint Pharmaceuticals2.3964 of 5 stars$13.34-1.7%$26.86+101.3%+5.2%$935.34M$43.27M-4.98120News CoverageALNTAllient2.7007 of 5 stars$48.25+5.1%$35.00-27.5%+160.0%$778.04M$529.97M56.102,525News CoverageAEHRAehr Test Systems1.9179 of 5 stars$25.52+8.6%$24.00-6.0%+57.9%$704.85M$58.97M-116.0090Gap UpTRNSTranscat3.6723 of 5 stars$69.86+2.0%$112.20+60.6%-47.7%$638.31M$278.42M48.851,245News CoveragePositive NewsCTKBCytek Biosciences1.2965 of 5 stars$3.96+2.9%$5.60+41.4%-23.6%$489.81M$200.45M-79.20500FEIMFrequency Electronics2.9628 of 5 stars$37.44+5.4%$43.00+14.9%+165.0%$346.29M$69.81M16.35200Analyst UpgradeGap DownSENSSenseonics2.0636 of 5 stars$0.42-0.2%$1.54+266.8%+14.4%$341.51M$25.47M-3.2290QSIQuantum-Si2.5855 of 5 stars$2.08+24.6%$3.48+67.1%+179.4%$338.17M$3.06M-3.06150News CoverageOptions VolumeGap UpHigh Trading VolumeMASS908 Devices1.2402 of 5 stars$7.87-1.6%$8.00+1.7%+138.4%$286.89M$59.63M-14.5760News CoveragePositive NewsAnalyst Revision Related Companies and Tools Related Companies 10x Genomics Alternatives Eyepoint Pharmaceuticals Alternatives Allient Alternatives Aehr Test Systems Alternatives Transcat Alternatives Cytek Biosciences Alternatives Frequency Electronics Alternatives Senseonics Alternatives Quantum-Si Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LAB) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Standard BioTools With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LAB Stock Alerts